Boosting HDL cholesterol with extended-release niacin (Niaspan) is a more effective way of slowing atherosclerosis in high-risk patients on long-term statin therapy than seeking additional LDL cholesterol reductions by adding ezetimibe (Zetia), researchers here reported.
Continue Reading
Download Source Document
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_b.png?x-id=cef25898-8870-4b52-ac47-77c87d19fed8)
No comments:
Post a Comment